Cargando…

The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Alzheimer’s Disease

Despite a wealth of knowledge gained in the past three decades concerning the molecular underpinnings of Alzheimer’s disease (AD), progress towards obtaining effective, disease modifying therapies has proven to be challenging. In this manner, numerous clinical trials targeting the production, aggreg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rohn, Troy T, Kim, Nayoung, Isho, Noail F, Mack, Jacob M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078432/ https://www.ncbi.nlm.nih.gov/pubmed/30090689 http://dx.doi.org/10.4172/2161-0460.1000439

Ejemplares similares

The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases
por: Abdelnour, Sameh A., et al.
Publicado: (2021)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
por: Bhardwaj, Shanu, et al.
Publicado: (2021)

A Survey of Validation Strategies for CRISPR-Cas9 Editing
por: Sentmanat, Monica F., et al.
Publicado: (2018)

Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
por: Papizan, James B., et al.
Publicado: (2021)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

CRISPR-Cas9 gene editing and human diseases
por: Jinka, Chaitra, et al.
Publicado: (2022)

CRISPR/Cas9 Essential Gene Editing in Drosophila
por: Osadchiy, I. S., et al.
Publicado: (2023)

A Fragment of Apolipoprotein E4 Leads to the Downregulation of a CXorf56 Homologue, a Novel ER-Associated Protein, and Activation of BV2 Microglial Cells
por: Pollock, Tanner B., et al.
Publicado: (2019)

Gene editing using CRISPR-Cas9 for the treatment of lung cancer
por: Castillo, Andres
Publicado: (2016)

Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
por: Gao, Qianqian, et al.
Publicado: (2019)

Transcriptome Analyses in BV2 Microglial Cells Following Treatment With Amino-Terminal Fragments of Apolipoprotein E
por: Pollock, Tanner B., et al.
Publicado: (2020)

Off-target effects in CRISPR/Cas9 gene editing
por: Guo, Congting, et al.
Publicado: (2023)

CRISPR/Cas9-gene editing approaches in plant breeding
por: Saini, Himanshu, et al.
Publicado: (2023)

The enhancement of CRISPR/Cas9 gene editing using metformin
por: Rollins, Jaedyn L., et al.
Publicado: (2023)

CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

Quality Control Strategy for CRISPR-Cas9-Based Gene Editing Complicated by a Pseudogene
por: Hanss, Zoé, et al.
Publicado: (2020)

Strategies and Methods for Improving the Efficiency of CRISPR/Cas9 Gene Editing in Plant Molecular Breeding
por: Zhou, Junming, et al.
Publicado: (2023)

Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
por: Giau, Vo Van, et al.
Publicado: (2018)

The potential of CRISPR/Cas9 genome editing for the study and treatment of intervertebral disc pathologies
por: Krupkova, Olga, et al.
Publicado: (2018)

CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
por: Liang, Puping, et al.
Publicado: (2015)

Outbred genome sequencing and CRISPR/Cas9 gene editing in butterflies
por: Li, Xueyan, et al.
Publicado: (2015)

Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system
por: Cheong, Taek-Chin, et al.
Publicado: (2016)

Applications of CRISPR/Cas9 for Gene Editing in Hereditary Movement Disorders
por: Im, Wooseok, et al.
Publicado: (2016)

Opportunities for CRISPR/Cas9 Gene Editing in Retinal Regeneration Research
por: Campbell, Leah J., et al.
Publicado: (2017)

Gene Editing and Crop Improvement Using CRISPR-Cas9 System
por: Arora, Leena, et al.
Publicado: (2017)

Cas9 immunity creates challenges for CRISPR gene editing therapies
por: Crudele, Julie M., et al.
Publicado: (2018)

Edition of TFAM gene by CRISPR/Cas9 technology in bovine model
por: de Oliveira, Vanessa Cristina, et al.
Publicado: (2019)

In Vitro Pre-validation of Gene Editing by CRISPR/Cas9 Ribonucleoprotein
por: Mehravar, Maryam, et al.
Publicado: (2019)

CRISPR/Cas9 Gene Editing: An Unexplored Frontier for Forest Pathology
por: Dort, Erika N., et al.
Publicado: (2020)

Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
por: Mirgayazova, Regina, et al.
Publicado: (2020)

AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria
por: Richards, Daelyn Y., et al.
Publicado: (2019)

Various Aspects of a Gene Editing System—CRISPR–Cas9
por: Janik, Edyta, et al.
Publicado: (2020)

How CRISPR/Cas9 Gene Editing Is Revolutionizing T Cell Research
por: Johansen, Kristoffer Haurum
Publicado: (2022)

Mini-Review: Transgenerational CRISPR/Cas9 Gene Editing in Plants
por: Impens, Lennert, et al.
Publicado: (2022)

Reversible RNA acylation for control of CRISPR–Cas9 gene editing
por: Habibian, Maryam, et al.
Publicado: (2019)

Application of CRISPR-Cas9 gene editing for congenital heart disease
por: Seok, Heeyoung, et al.
Publicado: (2021)

Application of CRISPR/Cas9 System for Efficient Gene Editing in Peanut
por: Neelakandan, Anjanasree K., et al.
Publicado: (2022)

CRISPR/Cas9-based gene activation and base editing in Populus
por: Yao, Tao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_laneqdhg9h7cu6e9vikk5nj739